Thus, DYRK3 mRNA was found significantly increased in highly invasive NSCLC cell lines compared with low invasive lines [164], while a strong DYRK3 expression was positively correlated with survival in glioma patients [165]. This evidence concerns the gene DYRK3 and non-small cell lung carcinoma.